151 – 160 of 212
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Epidermal Growth Factor Receptor (EGFR) in primary breast cancer-protein expression, but not gene copy number, gives important prognostic information in tamoxifen treated patients
2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.187-187(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic impact of array-based genomic profiles in esophageal squamous cell cancer
(
- Contribution to journal › Article
-
Mark
Early intravesical epirubicin instillation after transurethral resection for non-muscle invasive bladder cancer is inefficient for recurrent tumours
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.177-177(
- Contribution to journal › Published meeting abstract
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
(
- Contribution to journal › Article
-
Mark
Characterization Of Non-Small Cell Lung Cancer Using Tiling Resolution Bacterial Artificial Chromosome Microarrays
(
- Contribution to journal › Published meeting abstract
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
-
Mark
Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
(
- Contribution to journal › Article
-
Mark
Analys av HER2 i bröstcancer kvalitetssäkrad. Viktig behandlingsprediktiv och prognostisk faktor.
(
- Contribution to journal › Article
-
Mark
Egfr Amplifications And Mutations In Lung Cancer
(
- Contribution to journal › Published meeting abstract